Fill out the information below and be among the first to get the latest news about Rivfloza™ for primary hyperoxaluria type 1 (PH1).
All fields are required
An error occurred, please try again later.
Important Safety Information
What are the possible side effects of RIVFLOZA™?
The most common side effects of Rivfloza™ include injection site reactions, such as reddening, pain, bruising, rash, or dimple at the site of injection.
Please click here for Prescribing Information.
Rivfloza™ is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800-FDA-1088.
If you need assistance with prescription costs, help may be available. Call 1‑888-4PPA-NOW.
What is RIVFLOZA™?
Rivfloza™ (nedosiran) injection 80 mg, 128 mg, or 160 mg is a prescription medicine used to lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function.
It is not known if Rivfloza™ is safe and effective in children younger than 9 years of age.
What is RIVFLOZA™?
Rivfloza™ (nedosiran) injection 80 mg, 128 mg, or 160 mg is a prescription medicine used to lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function.
It is not known if Rivfloza™ is safe and effective in children younger than 9 years of age.
What is RIVFLOZA™?
Rivfloza™ (nedosiran) injection 80 mg, 128 mg, or 160 mg is a prescription medicine used to lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function.
It is not known if Rivfloza™ is safe and effective in children younger than 9 years of age.
What is RIVFLOZA™?
Rivfloza™ (nedosiran) injection 80 mg, 128 mg, or 160 mg is a prescription medicine used to lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function.
It is not known if Rivfloza™ is safe and effective in children younger than 9 years of age.
Important Safety Information
What are the possible side effects of RIVFLOZA™?
The most common side effects of Rivfloza™ include injection site reactions, such as reddening, pain, bruising, rash, or dimple at the site of injection.
Please click here for Prescribing Information.
Rivfloza™ is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800-FDA-1088.
If you need assistance with prescription costs, help may be available. Call 1‑888-4PPA-NOW.
Important Safety Information
What are the possible side effects of RIVFLOZA™?
The most common side effects of Rivfloza™ include injection site reactions, such as reddening, pain, bruising, rash, or dimple at the site of injection.
Please click here for Prescribing Information.
Rivfloza™ is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800-FDA-1088.
If you need assistance with prescription costs, help may be available. Call 1‑888-4PPA-NOW.
Important Safety Information
What are the possible side effects of RIVFLOZA™?
The most common side effects of Rivfloza™ include injection site reactions, such as reddening, pain, bruising, rash, or dimple at the site of injection.
Please click here for Prescribing Information.
Rivfloza™ is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800-FDA-1088.
If you need assistance with prescription costs, help may be available. Call 1‑888-4PPA-NOW.
What is RIVFLOZA™?
Rivfloza™ (nedosiran) injection 80 mg, 128 mg, or 160 mg is a prescription medicine used to lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function.
It is not known if Rivfloza™ is safe and effective in children younger than 9 years of age.
What is RIVFLOZA™?
Rivfloza™ (nedosiran) injection 80 mg, 128 mg, or 160 mg is a prescription medicine used to lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function.
It is not known if Rivfloza™ is safe and effective in children younger than 9 years of age.
Novo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, New Jersey 08536 U.S.A.
Rivfloza™ is a trademark of Novo Nordisk Health Care AG.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
© 2023 Novo Nordisk All rights reserved. US23NED00033 October 2023
